Investing.com - Health care conglomerate Johnson & Johnson (NYSE:JNJ) reported better-than-expected second quarter earnings on the back of strong revenue figures, it announced early Tuesday.
J&J said earnings per share came in at $1.66 in the second quarter, beating expectations for earnings of $1.55 per share. The company’s second quarter revenue totaled $19.5 billion, above expectations for revenue of $18.98 billion.
Domestic sales increased 14.9% in the second quarter, while international sales increased 4.4%, reflecting operational growth of 5% and a negative currency impact of 0.6%.
The firm now sees full year adjusted earnings per share in a range between $5.85 and $5.92, compared to expectations for adjusted earnings of $5.90 per share.
"Our strong second-quarter results reflect the continued success of our new product launches and the progress we have made in achieving our near-term priorities," said Alex Gorsky, Chairman and Chief Executive Officer.
Immediately after the earnings announcement, J&J (NYSE:JNJ)shares rose 0.6% in trading prior to the opening bell.
Meanwhile, the outlook for U.S. equity markets was modestly higher. The Dow futures indicated a gain of 0.15%, the S&P 500 pointed to a rise of 0.1%, while the Nasdaq 100 indicated an increase of 0.1%.